
Industrial components supplier NN (NASDAQ:NNBR) fell short of the market’s revenue expectations in Q2 CY2025, with sales falling 12.3% year on year to $107.9 million. On the other hand, the company’s outlook for the full year was close to analysts’ estimates with revenue guided to $445 million at the midpoint. Its non-GAAP profit of $0.02 per share was $0.02 above analysts’ consensus estimates.
Is now the time to buy NNBR? Find out in our full research report (it’s free).
NN’s second quarter results reflected a challenging market environment, particularly in the automotive segment, with sales declining year-over-year and missing Wall Street revenue expectations. Management attributed most of the sales shortfall to a major European automotive customer, while ongoing portfolio rationalization and cost initiatives helped maintain operating margins. CEO Harold Bevis highlighted the company’s ability to improve gross margins and win new business, stating, “We have launched over 70 new programs year-to-date and have more to go.”
Looking ahead, NN’s outlook is anchored by the continued ramp-up of new business launches and targeted investments in growth markets like medical and electrical components. Management expects these launches to support performance against a backdrop of industry uncertainty, particularly in automotive. CFO Chris Bohnert noted that guidance reflects “uncertainty from some of our top customers... as well as the unstable macroeconomic environment,” emphasizing the company’s reliance on new programs rather than a rebound in base markets.
Management’s remarks emphasized transformation progress, new business wins, and targeted investments as key to both recent performance and guidance.
NN’s near-term outlook is shaped by new program launches, cost control, and ongoing uncertainty in core end markets.
In coming quarters, the StockStory team will be monitoring (1) the pace and successful execution of new business program launches, (2) further progress in margin expansion from cost reduction efforts, and (3) the impact of targeted investments in medical and electrical market growth. Additional attention will be paid to M&A developments and NN’s ability to offset market volatility through portfolio diversification.
NN currently trades at $2.16, in line with $2.15 just before the earnings. Is there an opportunity in the stock?The answer lies in our full research report (it’s free).
When Trump unveiled his aggressive tariff plan in April 2025, markets tanked as investors feared a full-blown trade war. But those who panicked and sold missed the subsequent rebound that’s already erased most losses.
Don’t let fear keep you from great opportunities and take a look at Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
| Aug-06 | |
| Aug-05 | |
| Aug-05 | |
| Aug-05 | |
| Jul-23 | |
| Jul-20 | |
| Jul-20 | |
| Jul-13 | |
| Jul-10 | |
| Jul-06 | |
| Jul-01 | |
| Jun-29 | |
| Jun-29 | |
| Jun-29 | |
| Jun-22 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite